tiprankstipranks
Trending News
More News >

Rainer Erdtmann Insider Profile

4 Followers
Rainer Erdtmann, Sr. VP, IR and Admin at Pharmacyclics, holds 2.47M shares in Biomea Fusion (Ticker: BMEA), holds 50.00K shares in PolarityTE (Ticker: RGTPQ), holds 5.70K shares in Pharmacyclics (Ticker: PCYC).
tipranks
Rainer Erdtmann

Rainer Erdtmann
Pharmacyclics (PCYC)
Sr. VP, IR and Admin

Ranked #47,681 out of 103,225 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+1.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
0.00%
A breakdown of Rainer Erdtmann's holdings

Insider Roles

Biomea Fusion
(BMEA)
President, COO, Principal Financial Officer, and Principal Accounting Officer, Director
Summit Therapeutics
(SMMT)
Director
Roles that Rainer Erdtmann holds in companies

Most Profitable Insider Trade

Stock:
PolarityTE
(RGTPQ)
Rating:Informative Sell
Date:Dec 17, 2019 - Dec 17, 2020
Return:+75.40%
The most profitable trade made by Rainer Erdtmann

Rainer Erdtmann's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PCYC
Pharmacyclics
May 01, 2014
Uninformative Buy
16.40K
RGTPQ
PolarityTE
Dec 17, 2019
Informative Sell
78.66K
$7.80K
Summit Therapeutics
Director
Biomea Fusion
Aug 13, 2025
President, COO, Principal Financial Officer, and Principal Accounting Officer, Director
Uninformative Buy
$4.53M
List of latest transactions for each holding click on a transaction to see Rainer Erdtmann's performance on stock

Rainer Erdtmann insider profile FAQ

What is the percentage of profitable transactions made by Rainer Erdtmann?
The percentage of profitable transactions made by Rainer Erdtmann is 75%.
    What is the average return per transaction made by Rainer Erdtmann?
    The average return per transaction made by Rainer Erdtmann is 1.00%.
      What stocks does Rainer Erdtmann hold?
      Rainer Erdtmann holds: PCYC, RGTPQ, SMMT, BMEA stocks.
        What was Rainer Erdtmann’s latest transaction?
        Rainer Erdtmann latest transaction was an Uninformative Buy of ―.
          What was Rainer Erdtmann's most profitable transaction?
          Rainer Erdtmann’s most profitable transaction was an Informative Sell of RGTPQ stock on December 17, 2019. The return on the trade was 75.40%.
            What is Rainer Erdtmann's role in Pharmacyclics?
            Rainer Erdtmann's role in Pharmacyclics is Sr. VP, IR and Admin.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.